Overexpression of miR-124 could target BIRC3, thereby decreasing cIAP2 protein levels and inhibiting HCC proliferation and migration through regulating the NF-κB signaling pathway (64). The gene discussed is NFKB1; the disease is hepatocellular carcinoma.